Unfurling the Genetic Map of Sarcomas

    Cancer Discovery
    |August 25, 2016
    PubMed

    Insights

    Researchers identified new germline mutations linked to sarcoma development. Key DNA repair gene variants, such as BRCA2, ATM, ATR, and ERCC2, significantly increase sarcoma risk.

    Area of Science:

    • Genetics
    • Oncology
    • Molecular Biology

    Background:

    • Sarcomas are rare cancers originating in connective tissues.
    • Genetic predisposition plays a role in the development of various cancers, including sarcomas.
    • Understanding the genetic underpinnings of sarcoma is crucial for risk assessment and targeted therapies.

    Purpose of the Study:

    • To identify novel germline mutations associated with sarcoma susceptibility.
    • To investigate the contribution of DNA damage sensing and repair genes to sarcoma risk.
    • To elucidate the genetic landscape of hereditary sarcoma.

    Main Methods:

    • International collaborative research effort.
    • Germline DNA sequencing and mutation analysis.
    • Statistical analysis to determine the association between genetic variants and sarcoma development.

    Main Results:

    • Discovery of multiple new germline mutations implicated in sarcoma.
    • Significant association found between variants in DNA damage sensing and repair genes and increased sarcoma risk.
    • Specific genes identified include BRCA2, ATM, ATR, and ERCC2.

    Conclusions:

    • Germline mutations in DNA repair pathways are important contributors to sarcoma etiology.
    • BRCA2, ATM, ATR, and ERCC2 variants represent key genetic factors influencing sarcoma predisposition.
    • These findings may inform genetic screening and personalized risk management strategies for individuals at risk of sarcoma.

    Related Concept Videos

    Rous Sarcoma Virus (RSV) and Cancer01:03

    Rous Sarcoma Virus (RSV) and Cancer

    Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
    RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
    6.5K
    Karyotyping01:17

    Karyotyping

    Overview
    69.7K
    Tumor Progression02:07

    Tumor Progression

    Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
    Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
    7.8K
    Cancer-Critical Genes II: Tumor Suppressor Genes01:05

    Cancer-Critical Genes II: Tumor Suppressor Genes

    Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
    When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
    Such genes that act...
    10.0K
    Cancer-Critical Genes II: Tumor Suppressor Genes01:05

    Cancer-Critical Genes II: Tumor Suppressor Genes

    2.9K